CompoAtlas

SerratioPlus

SerratioPlus, licence 80057798: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Enzyme Science
NPN or DIN-HM
80057798
Status
Active licence
Licence date
30 January 2015
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Serrapeptase

Source : Serratia - Cellule entière

68.0 milligrammeNot calculated
Serrapeptase

Source : Serratia - Cellule entière

120000.0 SPUNot calculated

Non-medicinal ingredients

Citrate de calcium, Citrate de magnésium, Cellulose, Eau

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Capsule1.0 Jour(s)

Uses authorised in Canada

Text supplied in English because no French text is available.

Protease is a digestive aid. Protease helps digest proteins. Serratiopeptidase helps to reduce symptoms such as pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose, and/or throat infections. Serratiopeptidase is a mucolytic enzyme that helps break down mucous. Serratiopeptidase helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80057798

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line